Table II. CD16a N-glycopeptides identified in this study. V/V, V/F or F/F indicate donor allotype.
| Site | # | Peptide | Detergent solubilized |
Released by PMA |
# of unique glycoforms | |||
|---|---|---|---|---|---|---|---|---|
| NK08 (V/F) | NK09 (V/F) | NK11 (F/F) | NK12 (V/F) | NK13 (V/F) | ||||
| N38 | 1 | KDSVTLKCQGAYSPEDNSTQW | 13 | 10 | n.d. | 4 | 6 | 16 |
| 2 | KCQGAYSPEDNSTQW | 9 | 4 | 4 | 4 | 17 | 18 | |
| N45 | 1 | FHNE | 16 | 8 | 27 | n.d. | 2 | 29 |
| 2 | FHNESLISSQASSY | 20 | 25 | 6 | 15 | 37 | 40 | |
| N74 | 1 | RCQTNLSTLSDPVQLE | 10 | 4 | 4 | 8 | 17 | 17 |
| 2 | RCQTNLSTL | 8 | 2 | 7 | n.d. | n.d. | 10 | |
| N162 (V158) | 1 | VGSKNVSSE | 2 | n.d. | n.a. | 5 | 5 | 6 |
| 2 | CRGLVGSKNVSSE | 16 | 4 | n.a. | 8 | 20 | 29 | |
| 3 | FCRGLVGSKNVSSE | 1 | n.d. | n.a. | 2 | 5 | 6 | |
| N162 (F158) | 4 | GSKNVSSE | 3 | 2 | 8 | 1 | 1 | 9 |
| 5 | FGSKNVSSE | n.d. | n.d. | n.d. | 2 | 3 | 3 | |
| 6 | CRGLFGSKNVSSE | n.d. | n.d. | n.d. | 2 | 2 | 3 | |
| N169 | 1 | TVNITITQGL | 1 | n.d. | 3 | n.d. | n.d. | 3 |
| 2 | TVNITITQGLA | n.a. | n.a. | n.a. | 7 | 16 | 17 | |
| 3 | TVNITITQG | n.a. | 5 | n.a. | n.a. | n.a. | 5 | |
n.a. - not applicable.
n.d. - not detected.